摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氨基-2-羟基-5-甲基苯乙酮 | 70977-71-8

中文名称
3-氨基-2-羟基-5-甲基苯乙酮
中文别名
——
英文名称
3-acetyl-2-hydroxy-5-methylaniline
英文别名
1-(3-amino-2-hydroxy-5-methyl-phenyl)-ethanone;1-(3-Amino-2-hydroxy-5-methyl-phenyl)-aethanon;3-amino-2-hydroxy-5-methylacetophenone;3-Amino-2-hydroxy-5-methyl-acetophenon;1-(3-Amino-2-hydroxy-5-methylphenyl)ethanone
3-氨基-2-羟基-5-甲基苯乙酮化学式
CAS
70977-71-8
化学式
C9H11NO2
mdl
MFCD00798157
分子量
165.192
InChiKey
UFIFDZMJARCOCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    71-72 °C
  • 沸点:
    305.3±42.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2922509090

SDS

SDS:6638427b77e7b255de273ee2a22d6e16
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-(1H-tetrazol-5-yl)benzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides
    摘要:
    The synthesis and antiallergic activity of a series of 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and isomeric N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides is described. A relationship between structure and intravenous antiallergic activity in the rat passive cutaneous anaphylaxis (PCA) test has been established using a Hansch/Free-Wilson model and used to direct studies toward potent derivatives. The contribution of physicochemical properties to activity is discussed. One member of this series, N-(3-acetyl-5-fluoro-2-hydroxyphenyl)-1H-tetrazole-5-carboxamide (3f), which was selected for further evaluation, has an ID50 value of 0.16 mg/kg po and is 130 times more potent than disodium cromoglycate (DSCG) on intravenous administration.
    DOI:
    10.1021/jm00154a019
  • 作为产物:
    描述:
    2-羟基-5-甲基-3-硝基苯乙酮 在 palladium-carbon 氢气 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以to obtain 3.30 g (yield: 97%) of 3-amino-2-hydroxy-5-methylacetophenone as brown needle crystals的产率得到3-氨基-2-羟基-5-甲基苯乙酮
    参考文献:
    名称:
    Diarylmethoxypiperidine derivatives
    摘要:
    公开了一种由式(I)表示的二芳基甲氧基哌啶化合物:##STR1## 其中Ar.sup.1和Ar.sup.2分别表示苯基,该苯基可以被特定取代基取代,或者是吡啶基;X表示烷基或具有##STR2##的基团,其中n表示1到8的整数;Y表示氧原子或具有--CONH--的基团;Z表示至少具有规范中定义的一个特定取代基的苯基;以及其药学上可接受的盐。
    公开号:
    US05225559A1
点击查看最新优质反应信息

文献信息

  • [EN] QUINAZOLINONES DERIVATIVES FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, PREPARATION AND USE THEREOF<br/>[FR] DÉRIVÉS DE QUINAZOLINONES POUR LE TRAITEMENT DE LA STÉATOSE HÉPATIQUE NON ALCOOLIQUE, LEUR PRÉPARATION ET LEUR UTILISATION
    申请人:COUNCIL SCIENT IND RES
    公开号:WO2022003712A1
    公开(公告)日:2022-01-06
    The present invention described herein relates to a compound having Structure I for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I arecapable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.
    本发明描述了一种具有结构I的化合物,用于治疗通过抑制或调节泛素连接酶COP1酶产生生理上有益反应的疾病和紊乱,特别是用于治疗非酒精性脂肪肝病(NAFLD)。这些具有结构I的化合物能够增加脂肪三酸甘油酯脂解酶(ATGL)的水平。还提供了制备具有结构I的化合物的方法。
  • 2'Hydroxy tetrazole-5-carboxanilides and anti-allergic use thereof
    申请人:May & Baker Limited
    公开号:US04442115A1
    公开(公告)日:1984-04-10
    New tetrazole derivatives of the general formula: ##STR1## [wherein R.sup.1 represents a halogen atom, a straight- or branched-chain alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl or alkylsulphamoyl group, each such group containing from 1 to 6 carbon atoms, a dialkylsulphamoyl, dialkylamino, or dialkylcarbamoyl group (wherein the two alkyl groups may be the same or different and each contains from 1 to 4 carbon atoms), a straight- or branched-chain alkanoyl, alkoxycarbonyl, alkoxycarbonylamino, alkylcarbamoyl or alkanoylamino group containing from 2 to 6 carbon atoms, a cycloalkylcarbonyl group containing from 3 to 8 carbon atoms in the cycloalkyl moiety, or a hydroxy, formyl, nitro, trifluoromethyl, trifluoroacetyl, aryl, benzyloxycarbonylamino, amino, sulphamoyl, cyano, tetrazol-5-yl, carboxy, carbamoyl, benzyloxy, aralkanoyl or aroyl group, or a group of the formula: --CR.sup.2 .dbd.NOR.sup.3 II (wherein R.sup.2 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 5 carbon atoms, an aryl, aralkyl or trifluoromethyl group, or a cycloalkyl group containing from 3 to 8 carbon atoms, and R.sup.3 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 6 carbon atoms optionally substituted by a phenyl group, or represents an aryl group optionally substituted by one or more substituents selected from halogen atoms and straight- or branched-chain alkyl and alkoxy groups containing from 1 to 6 carbon atoms and hydroxy, trifluoromethyl and nitro groups), and m represents zero or an integer 1, 2 or 3, the substituents R.sup.1 being the same or different when m represents 2 or 3] possess pharmacological properties, in particular properties of value in the treatment of allergic conditions.
    新的四唑衍生物的一般化学式为:##STR1##[其中R.sup.1代表卤素原子,直链或支链烷基,烷氧基,烷硫基,烷基亚硫酰基,烷基磺酰基或烷基磺胺基,每个这样的基团含有1至6个碳原子,双烷基磺酰胺基,双烷基氨基或双烷基氨基甲酰基(其中两个烷基可能相同或不同,每个含有1至4个碳原子),直链或支链脂肪酰基,烷氧基羰基,烷氧基羰基氨基,烷基甲酰胺基或脂肪酰胺基含有2至6个碳原子,环烷基羰基含有3至8个碳原子的环烷基基团,或羟基,甲酰基,硝基,三氟甲基,三氟乙酰基,芳基,苄氧羰胺基,氨基,磺酰胺基,氰基,四唑-5-基,羧基,氨基甲酰基,苄氧基,芳基酰基或芳酰基,或式子:--CR.sup.2.dbd.NOR.sup.3 II(其中R.sup.2代表氢原子或含有1至5个碳原子的直链或支链烷基,芳基,芳基烷基或三氟甲基基团,或含有3至8个碳原子的环烷基基团,R.sup.3代表氢原子,或含有1至6个碳原子的直链或支链烷基基团,可选择地由苯基取代,或表示由一个或多个取代基选择的卤素原子和直链或支链烷基和烷氧基基团,含有1至6个碳原子和氢氧基,三氟甲基和硝基基团),m表示零或整数1、2或3,当m表示2或3时,取代基R.sup.1相同时或不同时]具有药理学性质,特别是在治疗过敏症状方面具有价值的性质。
  • DE2846931
    申请人:——
    公开号:——
    公开(公告)日:——
  • Transformation of Anionically Activated Trifluoromethyl Groups to Heterocycles under Mild Aqueous Conditions
    作者:Jennifer X. Qiao、Tammy C. Wang、Carol Hu、Jianqing Li、Ruth R. Wexler、Patrick Y. S. Lam
    DOI:10.1021/ol200326u
    日期:2011.4.1
    The (hetero)aromatic trifluoromethyl group is present in many biologically active molecules and is generally considered to be chemically stable. In this paper, a convenient one-step synthesis of C-C linked aryl-heterocycles or heteroaryl-heterocycles In good to excellent yields via the reaction of anionically activated trifluoromethyl groups with amino nucleophiles containing a second NH, OH, or SH nucleophile in 1 N sodium hydroxide is reported. The method has high functional group tolerability and is potentially useful in parallel synthesis.
  • Kasahara, Nippon Kagaku Zasshi, 1958, vol. 79, p. 335,337
    作者:Kasahara
    DOI:——
    日期:——
查看更多